Squarepoint Ops LLC Abb Vie Inc. Call Options Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $638,976 - $777,387	-3,900 Reduced 3.24%	116,600 $23 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $40.8 Million - $47.7 Million	-263,800 Reduced 68.64%	120,500 $20.7 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $42.9 Million - $48.8 Million	268,200 Added 231.01%	384,300 $70 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $11.8 Million - $13.3 Million	85,800 Added 283.17%	116,100 $18 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $2.36 Million - $2.94 Million	17,800 Added 142.4%	30,300 $4.08 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $4.34 Million - $5 Million	-30,000 Reduced 70.59%	12,500 $1.99 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $4.51 Million - $5.41 Million	32,600 Added 329.29%	42,500 $6.87 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $993,154 - $1.14 Million	-7,400 Reduced 42.77%	9,900 $1.33 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.68 Million - $2.13 Million	12,200 Added 239.22%	17,300 $2.65 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $739,088 - $917,000	-5,600 Reduced 52.34%	5,100 $827,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $268,575 - $339,825	-2,500 Reduced 18.94%	10,700 $1.45 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $3.4 Million - $3.86 Million	-32,000 Reduced 70.8%	13,200 $1.42 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $999,494 - $1.11 Million	-9,500 Reduced 17.37%	45,200 $5.09 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $3.37 Million - $3.71 Million	32,900 Added 150.92%	54,700 $5.92 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $1.55 Million - $2.1 Million	19,300 Added 772.0%	21,800 $2.34 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $17,182 - $20,166	200 Added 8.7%	2,500 $219,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $36,685 - $49,090	-500 Reduced 17.86%	2,300 $226,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $923,264 - $1.16 Million	-12,800 Reduced 82.05%	2,800 $248,000
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $711,674 - $855,636	11,300 Added 262.79%	15,600 $1.18 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $13,140 - $16,796	200 Added 4.88%	4,300 $313,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $316,274 - $372,239	4,100 New	4,100 $330,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account